Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

Marathon Oil Says Operations Only Experienced Temporary Impacts From Winter Storm Elliot That Have Been Addressed At This Time

– Reuters

byBenzinga Newsdesk

December 23, 2022

1 minute read

– Reuters

Why BioCryst Pharmaceuticals Stock Is Plunging Today

By Adam Eckert

Today, 10:02 AM

BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading significantly lower Friday after the company paused enrollment in clinical trials with BCX9930 while it investigates elevated serum creatinine levels seen in some patients.

BCRX

Burger King Teams Up With Robinhood To Give Bitcoin, Ether, Dogecoin Rewards

By Bibhu Pattnaik

Today, 10:02 AM

Restaurant Brands International Inc (NYSE: QSR)-owned fast food chain Burger King announced Monday it is planning to give away cryptocurrencies in association with the brokerage platfo

$DOGE

Legal
News

Lixte Biotechnology Granted European Patent Titled ‘CLINICAL REGIMEN FOR TREATING MYELODYSPLASTIC SYNDROME WITH PHOSPHATASE INHIBITOR’

By Benzinga Newsdesk

Today, 10:02 AM

https://data.epo.org/publication-server/pdf-document?pn=3407887&ki=B1&cc=EP

LIXT

Schlumberger: Q2 Earnings Insights

By Benzinga Insights

Today, 10:02 AM

Shares of Schlumberger (NYSE:SLB) moved higher by 1.7% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 500.00% over the past year to $0.30, which beat the estimate of $0.26.

SLB

Marathon Oil Says Operations Only Experienced Temporary Impacts From Winter Storm Elliot That Have Been Addressed At This Time

Related Posts

Why BioCryst Pharmaceuticals Stock Is Plunging Today

Burger King Teams Up With Robinhood To Give Bitcoin, Ether, Dogecoin Rewards

Lixte Biotechnology Granted European Patent Titled ‘CLINICAL REGIMEN FOR TREATING MYELODYSPLASTIC SYNDROME WITH PHOSPHATASE INHIBITOR’

Schlumberger: Q2 Earnings Insights